Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06K Hold
20
﹤0.01% 398
2025
Q4
$2.76K Hold
20
﹤0.01% 420
2025
Q3
$2.56K Hold
20
﹤0.01% 402
2025
Q2
$2.42K Buy
+20
New +$2.25K ﹤0.01% 396
2023
Q1
Sell
-123
Closed -$11.2K 462
2022
Q4
$11.2K Buy
+123
New +$10.4K ﹤0.01% 320
2022
Q2
Sell
-44
Closed -$4K 521
2022
Q1
$4K Buy
+44
New +$3.81K ﹤0.01% 439
2021
Q3
Sell
-49
Closed -$4K 511
2021
Q2
$4K Hold
49
﹤0.01% 391
2021
Q1
$4K Hold
49
﹤0.01% 364
2020
Q4
$5K Sell
49
-6,010
-99% -$525K ﹤0.01% 329
2020
Q3
$527K Buy
6,059
+485
+9% +$42K 0.25% 116
2020
Q2
$487K Buy
5,574
+194
+4% +$16.7K 0.26% 111
2020
Q1
$443K Buy
5,380
+272
+5% +$24.3K 0.31% 101
2019
Q4
$484K Sell
5,108
-52
-1% -$4.67K 0.29% 109
2019
Q3
$448K Buy
5,160
+4,985
+2,849% +$448K 0.28% 121
2019
Q2
$16K Sell
175
-20
-10% -$1.69K 0.01% 262
2019
Q1
$17K Hold
195
0.01% 231
2018
Q4
$15K Hold
195
0.01% 235
2018
Q3
$15K Hold
195
0.01% 233
2018
Q2
$13K Hold
195
0.01% 245
2018
Q1
$14K Hold
195
0.01% 249
2017
Q4
$15K Buy
+195
New +$14.7K 0.01% 229

Other funds holding NVS

NVWM LLC's NVS Position: Q1 2026 in Review

NVWM LLC held its Novartis (NVS) position steady in Q1 2026 at 20 shares worth $3.06K. The position accounts for ﹤0.01% of the portfolio, ranked #398.

NVWM LLC first reported a position in NVS in Q4 2017 and has held it in 21 quarters since. The position peaked at $527K in Q3 2020. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • NVWM LLC held 20 shares of Novartis worth $3.06K as of Q1 2026.
  • NVWM LLC left its Novartis share count unchanged in Q1 2026.
  • Novartis made up ﹤0.01% of NVWM LLC's portfolio in Q1 2026, its #398 holding.
  • NVWM LLC first reported a position in Novartis in Q4 2017 and has held it in 21 quarters since.
  • NVWM LLC's Novartis position peaked at $527K in Q3 2020.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.